Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

Recent & Breaking News (TSX:VRX)

25 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  February 28, 2017

Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance

PR Newswire February 28, 2017

Keep an Eye on These 12 Stocks for February 28, 2017

Benzinga.com  February 28, 2017

Earnings Scheduled For February 28, 2017

Benzinga.com  February 28, 2017

Valeant's High Debt Load Puts Q4 Focus On EBITDA Guidance

Benzinga.com  February 27, 2017

Valeant Announces Deployment Of Expanded Salix Sales Force To Capture Untapped Market Opportunity

PR Newswire February 27, 2017

Watch These 8 Huge Call Purchases In Monday Trade

Benzinga.com  February 27, 2017

Bausch + Lomb And Nicox Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod

PR Newswire February 27, 2017

Exclusive: Clinical-Stage Specialty Pharma EyeGate CEO On Relationship With Valeant

Benzinga.com  February 23, 2017

Research Reports Coverage on Healthcare Stocks -- Valeant Pharma, CVS Health, Express Scripts, and UnitedHealth

PR Newswire February 23, 2017

Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products

PR Newswire February 23, 2017

Watch These 7 Huge Put Purchases In Thursday Trade

Benzinga.com  February 23, 2017

Watch These 5 Huge Put Purchases In Wednesday Trade

Benzinga.com  February 22, 2017

Mid-Afternoon Market Update: Dow Surges Over 100 Points; Eyegate Pharmaceuticals Shares Spike Higher

Benzinga.com  February 21, 2017

Mid-Morning Market Update: Markets Open Higher; Wal-Mart Earnings Beat Views

Benzinga.com  February 21, 2017

Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product In Post-Operative Pain And Inflammation In Ocular Surgery Patients

PR Newswire February 21, 2017

Valeant Receives FDA Approval Of SILIQ™ (Brodalumab) For Moderate-To-Severe Plaque Psoriasis

PR Newswire February 16, 2017

Watch These 7 Huge Put Purchases In Tuesday Trade

Benzinga.com  February 14, 2017

Valeant Pharmaceuticals To Participate At Healthcare Conferences

PR Newswire February 13, 2017

Stock Options Trades: Covered-Call Alerts for Apple, Microchip Technology, Skechers, Valeant Pharmaceuticals and Yelp

PR Newswire February 13, 2017